Coral Laboratories Limited (BOM:524506)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceutical Formulations	859.00M	1.15B	836.60M	781.19M	756.11M
Pharmaceutical Formulations Growth	-25.31%	37.47%	7.09%	3.32%	-21.70%
Total	859.00M	1.15B	836.60M	781.19M	756.11M
Total Growth	-25.31%	37.47%	7.09%	3.32%	-21.70%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Ethopia	247.24M	157.72M	32.23M	95.76M
Ethopia Growth	56.76%	389.30%	-66.34%	-67.75%
India	219.04M	200.03M	275.04M	149.21M
India Growth	9.50%	-27.27%	84.33%	-15.04%
Rest of World	665.51M	463.24M	471.67M	487.26M
Rest of World Growth	43.66%	-1.79%	-3.20%	1.61%
Total	1.13B	820.99M	778.94M	732.23M
Total Growth	37.86%	5.40%	6.38%	-23.09%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 16, 2026

Data Sources Report a data error